The OTC derivatives marketplace is undergoing a radical transformation with the introduction of new regulatory rules and central counterparty clearing for some instruments. To participate in this new derivatives landscape, financial institutions must change existing post-trade processing and risk management practices, but these practical changes required may introduce additional risks for firms and the financial market at large.In a DerivSource podcast, a panel discusses the potential and unintended risks firms face with these new market developments including new concerns for systemic risk, increased capital requirements, the cost and additional risk inherent in new collateral management practices, documentation used and counterparty risk management.
Speakers:
Anu Munshi, partner B&B Structured Finance
Andrew Huszar, Managing Director, U.S. Head of OTC Derivatives Client Clearing at Morgan Stanley
